Skip to content

A study on cerebrospinal fluid immune atlas in sepsis-related encephalopathy

A study on cerebrospinal fluid immune atlas in sepsis-related encephalopathy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061093
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis-associated encephalopathy

Interventions

control group:N/A

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years; 2. Experimental group: According to the "Save Sepsis Movement: International Guidelines for the Treatment of Sepsis and Septic Shock 2021 Edition" jointly developed by the European Society of Critical Care Medicine (ESICM) and the American Society of Critical Care Medicine (SCCM), patients with sepsis and Patients with sepsis-related encephalopathy who need cerebrospinal fluid auxiliary examination to exclude intracranial infection; 3. Control group: patients diagnosed with sepsis and without sepsis-related encephalopathy.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Chronic liver and kidney failure; 3. Severe electrolyte imbalance; 4. After CPR; 5. Autoimmune diseases; 6. HIV infection; 7. Central nervous system infection; 8. Cerebrovascular accident; 9. Intracranial organic lesions; 10. The application of drugs to interfere with the observation of cognitive function; 11. The application of drugs has an biology effect on the immune system.

Design outcomes

Primary

MeasureTime frame
Single cell RNA-seq;RNA-seq;

Secondary

MeasureTime frame
cell morphology in cerebro-spinal fluid;S100ß/NSE/S100A8 in cerebrospinal fluid;peripheral blood biochemical indicators;cerebral cortex thickness and the density of grey matter and white matter;regional cerebral oxygen saturation;electroencephalogram waveform;sequential organ failure assessment;mortality in emergency department sepsis score;glasgow coma score;richmond agitation-sedation scale;the confusion assessment method for the intensive care unit;montreal cognitive assessment;

Countries

China

Contacts

Public ContactYanna Si

Nanjing First Hospital

siyanna@163.com+86 15366155715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026